UNITED THERAPEUTICS Corp - Common Stock (UTHR)

CUSIP: 91307C102

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / Common Stock
Shares outstanding
42,833,193
Total 13F shares
51,009,203
Share change
-1,385,462
Total reported value
$8,872,097,786
Put/Call ratio
70%
Price per share
$173.95
Number of holders
382
Value change
-$239,100,161
Number of buys
199
Number of sells
186

Quarterly Holders Quick Answers

What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - UNITED THERAPEUTICS Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of UTHR - UNITED THERAPEUTICS Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
10%
4,383,856
$755,930,000 31 Mar 2015
13F
VANGUARD GROUP INC
13F
Company
7.4%
3,161,383
$545,132,000 31 Mar 2015
13F
SCOPIA CAPITAL MANAGEMENT LP
13F
Company
5.6%
2,415,686
$416,549,000 31 Mar 2015
13F
BlackRock Fund Advisors
13F
Company
4.7%
2,017,571
$347,900,000 31 Mar 2015
13F
LSV ASSET MANAGEMENT
13F
Company
4.6%
1,966,736
$339,134,000 31 Mar 2015
13F
BLACKROCK ADVISORS LLC
13F
Company
3.8%
1,646,412
$283,899,000 31 Mar 2015
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
3.7%
1,564,129
$269,710,000 31 Mar 2015
13F
DEUTSCHE BANK AG\
13F
Company
3.6%
1,522,991
$262,612,000 31 Mar 2015
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
3.5%
1,488,542
$256,677,000 31 Mar 2015
13F
IRIDIAN ASSET MANAGEMENT LLC/CT
13F
Company
3.4%
1,448,124
$249,707,000 31 Mar 2015
13F
Palo Alto Investors LP
13F
Company
3.3%
1,429,928
$246,570,000 31 Mar 2015
13F
STATE STREET CORP
13F
Company
3.2%
1,374,589
$237,018,000 31 Mar 2015
13F
BlackRock Investment Management, LLC
13F
Company
3%
1,278,898
$220,527,000 31 Mar 2015
13F
AJO, LP
13F
Company
3%
1,276,190
$220,060,000 31 Mar 2015
13F
Amici Capital, LLC
13F
Company
2.2%
955,809
$164,815,000 31 Mar 2015
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
2.2%
934,266
$161,100,000 31 Mar 2015
13F
FIRST TRUST ADVISORS LP
13F
Company
2.2%
926,320
$159,730,000 31 Mar 2015
13F
TimesSquare Capital Management, LLC
13F
Company
2%
871,950
$150,355,000 31 Mar 2015
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
1.9%
813,458
$140,269,000 31 Mar 2015
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
1.9%
801,389
$138,187,000 31 Mar 2015
13F
Consonance Capital Management LP
13F
Company
1.7%
712,186
$122,806,000 31 Mar 2015
13F
Bank of New York Mellon Corp
13F
Company
1.4%
597,141
$102,968,000 31 Mar 2015
13F
BANK OF MONTREAL /CAN/
13F
Company
1.4%
582,246
$100,400,000 31 Mar 2015
13F
FRED ALGER MANAGEMENT, LLC
13F
Company
1.3%
556,677
$95,990,000 31 Mar 2015
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.1%
461,834
$79,636,000 31 Mar 2015
13F
Invesco Ltd.
13F
Company
1.1%
454,764
$78,416,000 31 Mar 2015
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1%
446,500
$76,992,000 31 Mar 2015
13F
NORTHERN TRUST CORP
13F
Company
1%
435,585
$75,110,000 31 Mar 2015
13F
NORGES BANK
13F
Company
0.94%
403,871
$69,641,000 31 Mar 2015
13F
PointState Capital LP
13F
Company
0.91%
391,600
$67,526,000 31 Mar 2015
13F
First Eagle Investment Management, LLC
13F
Company
0.87%
372,580
$64,246,000 31 Mar 2015
13F
York Capital Management Global Advisors, LLC
13F
Company
0.87%
372,240
$64,187,000 31 Mar 2015
13F
RUSSELL FRANK CO/
13F
Company
0.85%
362,819
$62,566,000 31 Mar 2015
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.81%
348,403
$60,076,000 31 Mar 2015
13F
MORGAN STANLEY
13F
Company
0.73%
311,063
$53,638,000 31 Mar 2015
13F
Gotham Asset Management, LLC
13F
Company
0.68%
291,077
$50,192,000 31 Mar 2015
13F
Allianz Asset Management GmbH
13F
Company
0.67%
285,334
$49,201,000 31 Mar 2015
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.62%
266,051
$45,877,000 31 Mar 2015
13F
GLENMEDE TRUST CO NA
13F
Company
0.62%
263,724
$45,474,000 31 Mar 2015
13F
COLUMBUS CIRCLE INVESTORS
13F
Company
0.61%
260,006
$44,834,000 31 Mar 2015
13F
LAZARD ASSET MANAGEMENT LLC
13F
Company
0.57%
245,359
$42,307,000 31 Mar 2015
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.57%
244,674
$42,190,000 31 Mar 2015
13F
TEACHERS ADVISORS, LLC
13F
Company
0.56%
241,012
$41,559,000 31 Mar 2015
13F
GUGGENHEIM CAPITAL LLC
13F
Company
0.55%
234,024
$40,355,000 31 Mar 2015
13F
SMITH ASSET MANAGEMENT GROUP LP
13F
Company
0.54%
230,356
$39,721,000 31 Mar 2015
13F
Jupiter Investment Management Ltd
13F
Company
0.54%
229,628
$39,595,000 31 Mar 2015
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.53%
226,679
$39,087,000 31 Mar 2015
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.52%
221,281
$38,157,000 31 Mar 2015
13F
FRONTIER CAPITAL MANAGEMENT CO LLC
13F
Company
0.49%
207,828
$35,837,000 31 Mar 2015
13F
JPMORGAN CHASE & CO
13F
Company
0.48%
206,610
$35,627,000 31 Mar 2015
13F

Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2015

As of 30 Jun 2015, UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by 382 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 51,009,203 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, SCOPIA CAPITAL MANAGEMENT LP, DEUTSCHE BANK AG\, STATE STREET CORP, IRIDIAN ASSET MANAGEMENT LLC/CT, BlackRock Institutional Trust Company, N.A., Palo Alto Investors, LLC, and BlackRock Advisors LLC. This page lists 382 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2015 vs Q1 2015 Across Filers

Q1 2015 holders
364
Q2 2015 holders
382
Holder diff
18
Investor Q1 2015 Shares Q2 2015 Shares Share Diff Share Chg % Q1 2015 Value $ Q2 2015 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.